Abstract

BackgroundThe lymphatic system controls tissue homeostasis by draining protein-rich lymph to the vascular system. Lymphangiogenesis, the formation of lymphatic vessels, is a normal event in childhood but promotes tumor spread and metastasis during adulthood. Blocking lymphangiogenesis may therefore be of therapeutic interest. Production of adenosine is enhanced in the tumor environment and contributes to tumor progression through stimulation of angiogenesis. In this study, we determined whether adenosine affects lymphangiogenesis.MethodsLymphatic endothelial cells (HMVEC-dLy) were cultured in presence of adenosine and their proliferation, migration and tube formation was assessed. Gelatin sponges embedded with the stable analogue of adenosine 2-chloro adenosine were implanted in mice ear and lymphangiogenesis was quantified. Mice were intravenously injected with adenoviruses containing expression vector for 5′-endonucleotidase, which plays a major role in the formation of adenosine.ResultsIn vitro, we observed that adenosine decreased the proliferation of lymphatic endothelial cells, their migration and tube formation. However, in vivo, gelatin sponges containing 2-chloro adenosine and implanted in mice ear displayed an elevated level of lymphangiogenesis (2.5-fold, p<0.001). Adenovirus-mediated over-expression of cytosolic 5′-nucleotidase IA stimulated lymphangiogenesis and the recruitment of macrophages in mouse liver. Proliferation of lymphatic endothelial cells was enhanced (2-fold, p<0.001) when incubated in the presence of conditioned medium from murine macrophages.ConclusionWe have shown that adenosine stimulates lymphangiogenesis in vivo, presumably through a macrophage-mediated mechanism. This observation suggests that blockade of adenosine receptors may help in anti-cancer therapies.

Highlights

  • Lymphatic vessels are found all over the human body except in certain tissues or organs such as epidermis, cartilage, brain, cornea, bone marrow and retina

  • A deleterious role of the lymphatic system has been evidenced in cancer, in which lymphatic vessels participate in the promotion of tumor growth and metastasis [3]

  • Macrophages are the main actors of inflammatory lymphangiogenesis [9], principally through the secretion of vascular endothelial growth factor-C (VEGF-C) and VEGF-D [2,7]

Read more

Summary

Introduction

Lymphatic vessels are found all over the human body except in certain tissues or organs such as epidermis, cartilage, brain, cornea, bone marrow and retina. A deleterious role of the lymphatic system has been evidenced in cancer, in which lymphatic vessels participate in the promotion of tumor growth and metastasis [3]. Through the secretion of growth factors and prolymphangiogenic cytokines, inflammatory cells stimulate lymphangiogenesis [2,6,7,8]. Macrophages are the main actors of inflammatory lymphangiogenesis [9], principally through the secretion of vascular endothelial growth factor-C (VEGF-C) and VEGF-D [2,7]. Other paracrine factors secreted by macrophages share pro-lymphangiogenic properties which drive the growth, morphogenesis and function of lymphatic endothelial cells (LEC) [10,11,12]. Lymphangiogenesis, the formation of lymphatic vessels, is a normal event in childhood but promotes tumor spread and metastasis during adulthood.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.